Surprisingly though, the effects on cell proliferation of either loss of Cks1 or its reversal by concomitant loss of p27Kip1 had no significant impact on the disease onset in the highly aggressive Myc-AML model (Figure 5C). This evidence concerns the gene CDKN1B and acute myeloid leukemia.